@inproceedings{inproceedings, title  = {{Dupilumab Efficacy and Safety up to 2 Years in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis}},

 url = {{}},

 year = {{2024}},

 month = {{1}},

 author = {{Su JC and Paller AS and Simpson EL and Siegfried EC and Cork MJ and Arkwright PD and Pinter A and Dubost-Brama A and Chen Z and Bansal A and Prescilla R et al}},

 volume = {{34}},

 journal = {{CRITICAL PUBLIC HEALTH}},

 issue = {{1}},

 pages = {{14-15}},

 note = {{Accessed on 2025/04/05}}}